Justin Verlander Threw Some Proverbial High Heat At Robinson Cano On Twitter After News Of His PED Suspension Broke
Well, well, well...looks like the jokes on Justin Verlander here. Not only because that response bears a stark and undeniable contrast to the one he had when it was his teammate getting suspended for the use of PED's...
...but also because the only thing the Astros' ace should have been counting was 'almost' (against Brandy's wishes, of course) after Robinson Cano beat his snarky little subtweet by a full nine minutes with an immediate press release that predictably claimed negligence...
In all seriousness, I'm having a tough time deciding which party I find more unbearable here. On one hand, Robinson Cano looks like an even bigger schmuck for cheating the game while his wallet continues to get fat off the more statistically slender years of a $240 million dollar deal. On the other hand, it's extremely hard to sympathize with a pitcher who is ultimately whining about a handful of tainted at-bats throughout the longevity of his $180 million dollar contract. I know the cyclical arguments regarding the use of steroids, or a - ahem - "steroid masking agent", aren't entirely monetary in nature. Competitive advantage is definitely still a factor in how fans, athletes, and leagues alike view PED's, but it didn't seem to be one that had Justin Verlander up in arms when it was benefiting him.
I don't know, I guess I would just have a much easier time relating to the thought process of both the guilty party and his most impassioned detractor if they weren't already set for f'n life. Give me an injury-plagued slugger that chose to jam a needle in his ass in hopes of turning his rookie contract into something that offers some long-term financial security and a young pitching import that's having his keep compromised by having the aforementioned slugger in his division. That's some financial risk/reward-driven animosity that I can get behind. But two guys who, at one point or another, set the insanely lucrative market for their respective positions aren't exactly tugging the strings at the heart of the steroid issue.